Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Studies on dermal fibroblasts have documented up to 70% increases in collagen I production at optimal concentrations of 1 nanomolar
What It Targets Our Tesamorelin peptides are designed to target: Visceral and central abdominal fat that persists despite diet and exercise and is linked to cardiometabolic risk. Changes in body composition such as increased trunk fat and reduced lean mass that accompany aging or metabolic dysfunction. Metabolic concerns like elevated triglycerides, insulin resistance, or features of metabolic syndrome where visceral fat plays a role. Clients who want a more defined midsection and improved fatmuscle balance through a medically supervised peptide strategy rather than surgery
doi: 10.1155/2016/9626427 147 AhmadSFAkoumAHorneAW
01 3D Body Scan Full composition analysis every 4 weeks to track real progress, not guesswork
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Clinical Trials: Studies have shown that patients receiving BPC-157 therapy experience significant improvements in pain and function
